Amphastar Pharmaceuticals, Inc. (AMPH)
Total Valuation
AMPH has a market cap or net worth of $2.09 billion. The enterprise value is $2.45 billion.
Market Cap | 2.09B |
Enterprise Value | 2.45B |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
Earnings Date | May 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
AMPH has 48.10 million shares outstanding. The number of shares has increased by 1.09% in one year.
Shares Outstanding | 48.10M |
Shares Change (YoY) | +1.09% |
Shares Change (QoQ) | -1.68% |
Owned by Insiders (%) | 22.04% |
Owned by Institutions (%) | 71.21% |
Float | 37.37M |
Valuation Ratios
The trailing PE ratio is 17.01 and the forward PE ratio is 11.69. AMPH's PEG ratio is 2.77.
PE Ratio | 17.01 |
Forward PE | 11.69 |
PS Ratio | 3.24 |
Forward PS | 2.68 |
PB Ratio | 3.26 |
P/FCF Ratio | 14.36 |
PEG Ratio | 2.77 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.87, with an EV/FCF ratio of 16.86.
EV / Earnings | 17.82 |
EV / Sales | 3.80 |
EV / EBITDA | 10.87 |
EV / EBIT | 12.47 |
EV / FCF | 16.86 |
Financial Position
The company has a current ratio of 2.17, with a Debt / Equity ratio of 0.98.
Current Ratio | 2.17 |
Quick Ratio | 1.66 |
Debt / Equity | 0.98 |
Debt / EBITDA | 2.77 |
Debt / FCF | 4.29 |
Interest Coverage | 7.24 |
Financial Efficiency
Return on equity (ROE) is 23.20% and return on invested capital (ROIC) is 12.66%.
Return on Equity (ROE) | 23.20% |
Return on Assets (ROA) | 10.60% |
Return on Capital (ROIC) | 12.66% |
Revenue Per Employee | $365,926 |
Profits Per Employee | $78,106 |
Employee Count | 1,761 |
Asset Turnover | 0.50 |
Inventory Turnover | 2.80 |
Taxes
In the past 12 months, AMPH has paid $31.83 million in taxes.
Income Tax | 31.83M |
Effective Tax Rate | 18.79% |
Stock Price Statistics
The stock price has increased by +17.27% in the last 52 weeks. The beta is 0.85, so AMPH's price volatility has been lower than the market average.
Beta (1Y) | 0.85 |
52-Week Price Change | +17.27% |
50-Day Moving Average | 50.21 |
200-Day Moving Average | 53.04 |
Relative Strength Index (RSI) | 40.80 |
Average Volume (30 Days) | 490,447 |
Short Selling Information
The latest short interest is 3.60 million, so 7.48% of the outstanding shares have been sold short.
Short Interest | 3.60M |
Short Previous Month | 3.72M |
Short % of Shares Out | 7.48% |
Short % of Float | 9.62% |
Short Ratio (days to cover) | 7.78 |
Income Statement
In the last 12 months, AMPH had revenue of $644.40 million and earned $137.55 million in profits. Earnings per share was $2.60.
Revenue | 644.40M |
Gross Profit | 351.12M |
Operating Income | 196.99M |
Pretax Income | 169.38M |
Net Income | 137.55M |
EBITDA | 225.48M |
EBIT | 196.54M |
Earnings Per Share (EPS) | $2.60 |
Balance Sheet
The company has $259.24 million in cash and $623.64 million in debt, giving a net cash position of -$364.40 million or -$7.58 per share.
Cash & Cash Equivalents | 259.24M |
Total Debt | 623.64M |
Net Cash | -364.40M |
Net Cash Per Share | -$7.58 |
Equity / Book Value | 639.42M |
Book Value Per Share | 13.29 |
Working Capital | 264.19M |
Cash Flow
In the last 12 months, operating cash flow was $183.50 million and capital expenditures -$38.17 million, giving a free cash flow of $145.34 million.
Operating Cash Flow | 183.50M |
Capital Expenditures | -38.17M |
Free Cash Flow | 145.34M |
FCF Per Share | $3.01 |
Margins
Gross margin is 54.49%, with operating and profit margins of 30.57% and 21.34%.
Gross Margin | 54.49% |
Operating Margin | 30.57% |
Pretax Margin | 26.28% |
Profit Margin | 21.34% |
EBITDA Margin | 34.99% |
EBIT Margin | 30.50% |
FCF Margin | 22.55% |
Dividends & Yields
AMPH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.09% |
Shareholder Yield | -1.09% |
Earnings Yield | 6.59% |
FCF Yield | 6.97% |
Analyst Forecast
The average price target for AMPH is $59.25, which is 34.02% higher than the current price. The consensus rating is "Buy".
Price Target | $59.25 |
Price Target Difference | 34.02% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 17.61% |
EPS Growth Forecast (5Y) | 27.66% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
AMPH has an Altman Z-Score of 2.88 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.88 |
Piotroski F-Score | 6 |